Thus, the existing dogma in the field is that while physiological leptin concentrations may exert endothelium-dependent vasodilatory effects, pathophysiological elevated leptin levels akin to obesity and diabetes exhibit multiple proatherogenic properties. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.